Christine M Corradino, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Meadowlands Pkwy Fl 2, Secaucus, NJ 07094 Phone: 844-300-4677 Fax: 201-392-3571 |
Dr. Armando Ivan Martinez, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Not Enrolled in Medicare Practice Location: 405 County Avenue, Secaucus, NJ 07094 Phone: 201-319-1611 Fax: 201-319-1233 |
Paul Rothenberg, Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 38 Meadowlands Pkwy, Secaucus, NJ 07094 Phone: 551-205-8081 |
News Archive
In a scathing article for the Medical Journal of Australia published on Monday, GP Dr Tony Webber has described the Medicare scheme as a "monster". He wrote, "I estimate that $2 billion to $3 billion are spent inappropriately each year." As former chief of the Professional Services Review - set up to police Medicare - he said he gained insight into how dysfunctional the system had become.
Agilent Technologies Inc., today announced the availability of two Greenhouse Gases (GHG) Analyzers for simultaneous analysis of methane (CH4), carbon dioxide (CO2), and nitrous oxide (N2O) in air samples. The analyzers also can be used for soil gas analysis or plant breathing studies, where the samples contain CH4, N2O, and CO2. Both analyzers easily can be expanded to determine sulfur hexafluoride (SF6).
Baum Hedlund announces that Taiwanese hemophiliacs infected by HIV-contaminated medications have petitioned the United States Supreme Court to allow their claims to proceed in California. Their suits contend that California-based defendants illegally used paid plasma donors at high risk for transmitting blood-borne diseases (i.v. drug users, prisoners, and promiscuous urban gay males) to make injected anti-hemophilia medications.
In the first major trial of its kind, Cleveland Clinic researchers used a blinded rechallenge with atorvastatin or placebo to objectively confirm the presence of muscle-related symptoms in patients with a history of intolerance to multiple statins and found that evolocumab (a PCSK9 inhibitor) was a more effective option to lower cholesterol than ezetimibe in these patients.
› Verified 7 days ago